Study of rSIFN-co for Patients With Advanced Solid Tumors

Clinical trial NCT02464007 · TERMINATED

Trial details

NCT number: NCT02464007
Sponsor: Sichuan Huiyang Life Science and Technology Corporation
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignancies Including Melanoma, Kidney, Lung, Colorectal, Prostate, Neuroendocrine Tumor

Start date: 2016-01-01
Primary completion: 2024-11-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.